Sign In
Buy JAZZ
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
Wells Fargo Maintains Overweight on Jazz Pharmaceuticals, Lowers Price Target to $162
12:00am, Thursday, 30'th Apr 2020BRIEF-Jazz Pharma Stops Enrollment In Phase 3 Study Evaluating Defibrotide For Prevention Of Veno-Occlusive Disease
08:25pm, Wednesday, 29'th Apr 2020
Jazz Pharmaceuticals PLC:
Jazz Pharmaceuticals Stops Enrollment in Phase 3 Study Evaluating Defibrotide for the Prevention of Veno-Occlusive Disease
08:05pm, Wednesday, 29'th Apr 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that enrollment in the Phase 3 clinical study of defibrotide for the prevention of hepatic veno-occlusive disease (VOD) post-hematopoietic stem-
Jazz Pharmaceuticals stops enrollment in Phase 3 study of defibrotide JAZZ
09:13am, Wednesday, 29'th Apr 2020
Jazz Pharmaceuticals stops enrollment in Phase 3 study of defibrotide JAZZ
Jazz Pharmaceuticals Stops Enrollment For Its Phase 3 Study Evaluating Defibrotide For The Prevention Of Veno-Occlusive Disease
12:00am, Wednesday, 29'th Apr 2020At His Centennial, a Jazz Pioneer Still Rings True
08:19pm, Tuesday, 28'th Apr 2020
John Lewis was a visionary pianist who imagined a different look, sound and esteem for jazz.
Jazz Pharmaceuticals (JAZZ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:33pm, Tuesday, 28'th Apr 2020
Jazz (JAZZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jazz Pharmaceuticals (JAZZ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:33pm, Tuesday, 28'th Apr 2020
Jazz (JAZZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Jazz (JAZZ) Keep the Earnings Surprise Streak Alive?
04:10pm, Tuesday, 28'th Apr 2020
Jazz (JAZZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Can Jazz (JAZZ) Keep the Earnings Surprise Streak Alive?
04:10pm, Tuesday, 28'th Apr 2020
Jazz (JAZZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Can This Small-Cap Biotech Win a $1 Billion Market Opportunity for Narcolepsy?
02:48pm, Tuesday, 28'th Apr 2020
Will a small change in a drug's method of delivery be enough to generate over $1 billion in new sales?
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by GW Henssler & Associates Ltd.
10:28am, Tuesday, 28'th Apr 2020
GW Henssler & Associates Ltd. cut its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 16.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. Th
Jazz Pharmaceuticals (JAZZ) Gets a Buy Rating from Oppenheimer
10:24am, Tuesday, 28'th Apr 2020
Oppenheimer analyst Esther Rajavelu maintained a Buy rating on Jazz Pharmaceuticals (JAZZ) today and set a price target of $154.00. The company's shares
Jazz Pharmaceuticals (JAZZ) Gets a Buy Rating from Oppenheimer
10:24am, Tuesday, 28'th Apr 2020
Oppenheimer analyst Esther Rajavelu maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) today and set a price
